Milan, Italy

M Cristina Geroni

This inventor holds 1 USPTO granted patent. Top assignee: Nerviano Medical Sciences S.r.l.. Active years: 2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: M Cristina Geroni. Retrieved from https://idiyas.com/inventor/m-cristina-geroni

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2014

Loading Chart...
1 patent (USPTO):Explore Patents

Title: M Cristina Geroni: Innovator in Tumor Therapy

Introduction

M Cristina Geroni is a notable inventor based in Milan, Italy. He has made significant contributions to the field of oncology through his innovative research and development of therapeutic agents.

Latest Patents

Geroni holds a patent for a combined therapy against tumors, which includes substituted acryloyl distamycin derivatives and platinum derivatives. This patent describes compounds that are α-halogenoacryloyl distamycin derivatives, particularly effective in treating tumors that overexpress the GSH/GSTs system. These compounds are designed to be cytotoxic agents, especially for tumors that are poorly responsive or resistant to conventional antitumor therapies.

Career Highlights

Throughout his career, Geroni has been associated with Nerviano Medical Sciences S.r.l., where he has focused on developing advanced therapeutic solutions for cancer treatment. His work has been instrumental in pushing the boundaries of current cancer therapies.

Collaborations

Geroni has collaborated with esteemed colleagues such as Paolo Cozzi and Italo Beria, contributing to a dynamic research environment that fosters innovation in cancer treatment.

Conclusion

M Cristina Geroni's work exemplifies the intersection of innovation and medical science, particularly in the fight against cancer. His contributions continue to pave the way for new therapeutic strategies that may improve patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…